Global Biomarker Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Biomarker Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Consumables
  • 1.4.3 Service
• 1.5 Market by Application
  • 1.5.1 Global Biomarker Market Share by Application: 2020 VS 2026
  • 1.5.2 Diagnostics Development
  • 1.5.3 Drug Discovery and Development
  • 1.5.4 Disease-Risk
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Biomarker Market Perspective (2015-2026)
• 2.2 Biomarker Growth Trends by Regions
  • 2.2.1 Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Biomarker Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Biomarker Players by Market Size
  • 3.1.1 Global Top Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Biomarker Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Biomarker Market Concentration Ratio
  • 3.2.1 Global Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Biomarker Revenue in 2019
• 3.3 Biomarker Key Players Head office and Area Served
• 3.4 Key Players Biomarker Product Solution and Service
• 3.5 Date of Enter into Biomarker Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Biomarker Forecasted Market Size by Type (2021-2026)

5 Biomarker Breakdown Data by Application (2015-2026)

• 5.1 Global Biomarker Market Size by Application (2015-2020)
• 5.2 Global Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biomarker Market Size (2015-2020)
• 6.2 Biomarker Key Players in North America (2019-2020)
• 6.3 North America Biomarker Market Size by Type (2015-2020)
• 6.4 North America Biomarker Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Biomarker Market Size (2015-2020)
• 7.2 Biomarker Key Players in Europe (2019-2020)
• 7.3 Europe Biomarker Market Size by Type (2015-2020)
• 7.4 Europe Biomarker Market Size by Application (2015-2020)

8 China

• 8.1 China Biomarker Market Size (2015-2020)
• 8.2 Biomarker Key Players in China (2019-2020)
• 8.3 China Biomarker Market Size by Type (2015-2020)
• 8.4 China Biomarker Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Biomarker Market Size (2015-2020)
• 9.2 Biomarker Key Players in Japan (2019-2020)
• 9.3 Japan Biomarker Market Size by Type (2015-2020)
• 9.4 Japan Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Biomarker Market Size (2015-2020)
• 10.2 Biomarker Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Biomarker Market Size by Type (2015-2020)
• 10.4 Southeast Asia Biomarker Market Size by Application (2015-2020)

11 India

• 11.1 India Biomarker Market Size (2015-2020)
• 11.2 Biomarker Key Players in India (2019-2020)
• 11.3 India Biomarker Market Size by Type (2015-2020)
• 11.4 India Biomarker Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Biomarker Market Size (2015-2020)
• 12.2 Biomarker Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Biomarker Market Size by Type (2015-2020)
• 12.4 Central & South America Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 QIAGEN N.V. (Netherlands)
  • 13.1.1 QIAGEN N.V. (Netherlands) Company Details
  • 13.1.2 QIAGEN N.V. (Netherlands) Business Overview and Its Total Revenue
  • 13.1.3 QIAGEN N.V. (Netherlands) Biomarker Introduction
  • 13.1.4 QIAGEN N.V. (Netherlands) Revenue in Biomarker Business (2015-2020))
  • 13.1.5 QIAGEN N.V. (Netherlands) Recent Development
• 13.2 PerkinElmer, Inc. (U.S.)
  • 13.2.1 PerkinElmer, Inc. (U.S.) Company Details
  • 13.2.2 PerkinElmer, Inc. (U.S.) Business Overview and Its Total Revenue
  • 13.2.3 PerkinElmer, Inc. (U.S.) Biomarker Introduction
  • 13.2.4 PerkinElmer, Inc. (U.S.) Revenue in Biomarker Business (2015-2020)
  • 13.2.5 PerkinElmer, Inc. (U.S.) Recent Development
• 13.3 Merck Millipore (U.S.)
  • 13.3.1 Merck Millipore (U.S.) Company Details
  • 13.3.2 Merck Millipore (U.S.) Business Overview and Its Total Revenue
  • 13.3.3 Merck Millipore (U.S.) Biomarker Introduction
  • 13.3.4 Merck Millipore (U.S.) Revenue in Biomarker Business (2015-2020)
  • 13.3.5 Merck Millipore (U.S.) Recent Development
• 13.4 Bio-Rad Laboratories, Inc. (U.S.)
  • 13.4.1 Bio-Rad Laboratories, Inc. (U.S.) Company Details
  • 13.4.2 Bio-Rad Laboratories, Inc. (U.S.) Business Overview and Its Total Revenue
  • 13.4.3 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Introduction
  • 13.4.4 Bio-Rad Laboratories, Inc. (U.S.) Revenue in Biomarker Business (2015-2020)
  • 13.4.5 Bio-Rad Laboratories, Inc. (U.S.) Recent Development
• 13.5 Enzo Biochem, Inc. (U.S.)
  • 13.5.1 Enzo Biochem, Inc. (U.S.) Company Details
  • 13.5.2 Enzo Biochem, Inc. (U.S.) Business Overview and Its Total Revenue
  • 13.5.3 Enzo Biochem, Inc. (U.S.) Biomarker Introduction
  • 13.5.4 Enzo Biochem, Inc. (U.S.) Revenue in Biomarker Business (2015-2020)
  • 13.5.5 Enzo Biochem, Inc. (U.S.) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer